2018
DOI: 10.1007/s00292-018-0435-9
|View full text |Cite|
|
Sign up to set email alerts
|

Anforderungen an eine standortübergreifende Biobanken-IT-Infrastruktur

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 8 publications
0
8
0
Order By: Relevance
“…An additional functionality that distinguishes the Sample Locator from the search applications under review is that it limits the results visualization to the aggregated sample count from the whole GBA network for anonymous researchers. Only after a researcher’s authentication and log-in, the counts per biobank location are additionally displayed [ 6 ]. Further, after the search, the Sample Locator forwards the user directly to the Negotiator, a dedicated communication tool to help request material from relevant biobanks and negotiate the terms involved based on the actual planned research project.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…An additional functionality that distinguishes the Sample Locator from the search applications under review is that it limits the results visualization to the aggregated sample count from the whole GBA network for anonymous researchers. Only after a researcher’s authentication and log-in, the counts per biobank location are additionally displayed [ 6 ]. Further, after the search, the Sample Locator forwards the user directly to the Negotiator, a dedicated communication tool to help request material from relevant biobanks and negotiate the terms involved based on the actual planned research project.…”
Section: Discussionmentioning
confidence: 99%
“…To align with the overarching goal of improving patient care by strengthening medical research, increased efforts have recently been made to support the secondary use of data generated in the treatment context [ 1 - 4 ]. In Germany, initiatives such as the Medical Informatics Initiative [ 5 ] or the German Biobank Alliance (GBA) [ 6 ] have emerged to establish an appropriate infrastructure for this endeavor. Coordinated by the German Biobank Node (GBN), the GBA has taken up the challenge of creating a cross-location biobank network to support biospecimen-based research projects.…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, MIRACUM (Medical Informatics in Research and Care in University Medicine) [9], one of the four MII consortia, has set itself the task of carrying out a comparative evaluation of existing tools with regard to their usability to identify the most user-friendly system, and thus forms the best basis for developing a harmonized tool. As the implementation of such a platform was intended to take place as quickly as possible, a preselection of three implementations already used in the consortium (also freely accessible for researchers in Germany) was made for the usability evaluation: the MIRACUM i2b2 (Informatics for Integrating Biology and the Bedside) [10] feasibility platform, OHDSI's (Observational Health Data Sciences and Informatics) ATLAS [11,12], and the Sample Locator [13] of the German Biobank Alliance (GBA) [14,15]. The selection was based on the fact that they differed greatly in terms of complexity and functionality, so good coverage was expected.…”
Section: Introductionmentioning
confidence: 99%
“…The definition of machine-interpretable, complex mappings has already been investigated in the past (see, e.g., Mate et al 52 ). The German Biobank Node and German Biobank Alliance projects, 10 23 53 which are working on establishing the German national node for BBMRI-ERIC and whose members are active contributors to the Samply software environment, are currently discussing how the MDR could be extended to store such transformation rules.…”
Section: Discussion and Outlookmentioning
confidence: 99%